SCHEMBL31349528

SCHEMBL31349528

O=C1CC(n2cnc3cc(O)cc(C(F)(F)F)c32)CN1

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 3/20 0.42
▸ ESR2 Q92731 6/20 0.32
▸ ESR1 P03372 5/20 0.32
▸ SCN8A Q9UQD0 2/20 0.31
▸ SLC5A1 P13866 7/20 0.31
▸ IRAK4 Q9NWZ3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31349568 0.86 ABL1 (0.41) ABL1
SCHEMBL31349532 0.80 ABL1 (0.41) ABL1SLC5A1
SCHEMBL31349450 0.78 ABL1 (0.36) ABL1
SCHEMBL31436512 0.78 ESR2 (0.30) ESR2
SCHEMBL25316223 0.75 AR (0.42) ABL1
SCHEMBL26023696 0.75 AR (0.42) ABL1
SCHEMBL30507171 0.75 AR (0.42) ABL1
SCHEMBL31349584 0.74 MAP3K12 (0.36) ESR2ESR1
SCHEMBL31349496 0.73 HCAR1 (0.39) ABL1
SCHEMBL31698068 0.65 ABL1 (0.37) ABL1ESR2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743078-A2 APOL1 INHIBITORS AND METHODS OF USE Maze Therapeutics, Inc. (US) 2026-05-20 — — EP disclosed
WO-2025015104-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2025-01-16 — — WO disclosed
Send feedback